Frontiers in Aging Neuroscience · 2018 · 169 citations · 43 references
Life SciencesMicrobiologyNeuroscienceMedical MicrobiologyMicrobial PathogenesisMycologyBacterial InfectionsFungal InfectionsFungal PathogenesisFungal PathologyNeuropathology Of InfectionPathogen BiologyAlzheimer Disease DementiaDisseminated Fungal InfectionFungal DetectionFungal Pathogen DetectionFungal Pathogenicity FactorsNervous Tissue Histology
Alzheimer’s disease (AD) is the leading cause of dementia in elderly people. The etiology of this disease remains a matter of intensive research in many laboratories. We have advanced the idea that disseminated fungal infection contributes to the etiology of AD. Thus, we have demonstrated that fungal proteins and DNA are present in nervous tissue from AD patients. More recently, we have reported that bacterial infections can accompany these mycoses, suggesting that polymicrobial infections exist in AD brains. In the present study, we have examined fungal and bacterial infection in brain tissue from AD patients and control subjects by immunohistochemistry. In addition, we have documented the fungal and bacterial species in brain regions from AD patients and control subjects by next-generation sequencing (NGS). Our results from the analysis of ten AD patients reveal a variety of fungal and bacterial species, although some were more prominent than others. The fungal genera more prevalent in AD patients were Alternaria, Botrytis, Candida and Malassezia. We also compared these genera with those found in elderly and younger subjects. One of the most prominent genera in control subjects was Fusarium. Principal component analysis clearly indicated that fungi from frontal cortex samples of AD brains clustered together and differed from those of equivalent control subjects. Regarding bacterial infection, the phylum Proteobacteria was the most prominent in both AD patients and controls, followed by Firmicutes, Actinobacteria and Bacteroides. At the family level, Burkholderiaceae and Staphylococcaceae exhibited higher percentages in AD brains than in control brains. These findings could be of interest to guide targeted antimicrobial therapy for AD patients. Moreover, the variety of microbial species in each patient may constitute a basis for a better understanding of the evolution and severity of clinical symptoms in each patient.
43
A human gut microbial gene catalogue established by metagenomic sequencing
Junjie Qin, Ruiqiang Li, Jeroen Raes et al. · Nature · 2010 · 11.7K citations · Full text
Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis
José U. Scher, Andrew Sczesnak, Randy Longman et al. · eLife · 2013 · 2.1K citations · Full text
Alterations of the human gut microbiome in multiple sclerosis
Sushrut Jangi, Roopali Gandhi, Laura M. Cox et al. · Nature Communications · 2016 · 1.3K citations · Full text
Human oral, gut, and plaque microbiota in patients with atherosclerosis
Omry Koren, Aymé Spor, Jenny Felin et al. · Proceedings of the National Academy of Sciences · 2010 · 1.2K citations